-
SARS-CoV-2 Nsp1 Blocks mRNA Export
2026-09-16
Zhang et al. showed that SARS-CoV-2 Nsp1 suppresses host gene expression by targeting the NXF1–NXT1 mRNA export receptor, preventing adaptor engagement and nuclear pore docking. Rescue by increased NXF1 connects this mechanism to antiviral defense and provides a useful framework for studying how viral proteins reprogram nuclear RNA transport.
-
Cleavage-Resistant TREM2 Enhances Macrophage Efferocytosis
2026-09-15
Dong et al. engineered a synthetic cleavage-resistant TREM2 receptor that preserves macrophage efferocytosis despite inflammatory ADAM17 activity. Phosphatidylserine-functionalized lipid nanoparticles delivered CRT mRNA in situ, producing macrophages that reduced apoptotic-cell accumulation and inflammation in mouse models of metabolic-dysfunction-associated steatohepatitis and atherosclerosis.
-
Open-Platform DLP for 96-Well Hydrogel Printing
2026-09-15
The reference study presents a low-cost, open-platform digital light printer that fabricates two-dimensional hydrogel layers and locally activates biomolecules in 96-well plates. Its LabVIEW-controlled projection system improves plate-wide consistency while allowing changes in wavelength, vessel format, hydrogel shape, and ink composition without redesigning the entire instrument.
-
NHS-Biotin Workflows for Protein Labeling
2026-09-14
NHS-Biotin enables stable amine-directed labeling for protein detection, purification, and intracellular assay development. This workflow connects practical biotinylation controls with the peptidisc-assisted nanobody clustering strategy reported in a recent preprint, helping researchers preserve avidity while minimizing steric disruption.
-
Ionomycin Free Acid in FAK Calcium Research
2026-09-14
Ionomycin free acid offers a controlled way to examine how calcium perturbation may intersect with FAK stability in triple-negative breast cancer models. This article translates the FAISL–FAK study into assay decisions while clarifying what the calcium ionophore can—and cannot—demonstrate.
-
V5 Epitope Tagging: From Detection to Dynamics
2026-09-13
The V5 Epitope Tag Peptide is more than a convenient antigen: it can serve as a defined control, assay-calibration reagent, and bridge between recombinant protein expression, immunodetection, and emerging single-molecule imaging. This article connects the GKPIPNPLLGLDST peptide to antibody kinetics, translational assay design, and practical workflow decisions.
-
Gly-Gly-Phe-Gly: A Rigorous Linker Guide
2026-09-12
Explore how Gly-Gly-Phe-Gly (GGFG) functions as a sequence-defined peptide spacer for bioconjugation, peptide engineering, and biomaterial construction. This guide also translates modern peptide–metal-ion methodology into practical assay and linker-design decisions while clearly separating evidence from workflow recommendations.
-
ETS1–SENP2 Axis Restrains Mitophagy in BPD
2026-09-11
The reference study identifies ETS1 as a transcriptional regulator that protects against hyperoxia-associated bronchopulmonary dysplasia by activating the SENP2/HSPA8/FUNDC1 axis. Its findings connect FUNDC1 deSUMOylation, chaperone-mediated degradation, and excessive mitophagy, providing a mechanistic framework for studying mitochondrial quality control in developing lung tissue.
-
Dual-Action p38α Inhibition and Dephosphorylation
2026-09-11
The reference preprint shows that selected kinase inhibitors can do more than occupy the p38α active site: they can also stabilize an activation-loop conformation that accelerates WIP1-mediated dephosphorylation. This mechanism links kinase inhibition with phosphatase-driven signal termination and offers a structural framework for designing more durable and selective p38 MAPK inhibitors.
-
Lassa Virus Spike pH Switching and Entry Inhibition
2026-09-10
This 2025 Cell Host & Microbe study defines how pH-dependent structural transitions prepare the Lassa virus spike for receptor release and membrane fusion. High-resolution structural analysis and ARN-75039 validation connect early transmembrane remodeling with later spike opening, providing a mechanistic framework for antiviral entry inhibition and for interpreting carefully preserved structural samples.
-
Regulated N-Glycosylation at the Secretory Translocon
2026-09-10
This study defines how CCDC134 and OST-A regulate GRP94 glycosylation during synthesis at the ER translocon. Structural and functional evidence shows that a nascent GRP94 segment remodels the translocon, suppresses inappropriate OST-A activity, and limits access by OST-B, providing a mechanistic explanation for regulated N-glycosylation and its links to proteostasis.
-
SmD2 Acetylation and PARP Sensitivity in HCC
2026-09-09
This 2024 Nature Communications study identifies acetylation-dependent control of the spliceosome protein SmD2 as a regulator of BRCA1/FANC cassette exons, DNA repair, and PARP inhibitor response in hepatocellular carcinoma. Its findings support a mechanistic strategy in which HDAC2 or SmD2 regulation is combined with PARP inhibition, particularly in HCC models that do not depend on canonical BRCA1/2 deficiency.
-
Canagliflozin: SGLT2 Inhibitor Research Guide
2026-09-09
Canagliflozin is a selective SGLT2 inhibitor used to study renal glucose reabsorption inhibition and glucose metabolism modulation. Recent mouse evidence links treatment with proximal-tubule mitochondrial remodeling, improved bioenergetics in males, and reduced albuminuria under a hypertensive-diabetic model.
-
BOP Reagent for Peptide and Prodrug Design
2026-09-08
BOP reagent is a solid peptide coupling reagent for carboxyl group activation and amide bond formation. The supplier reports 98% purity, organic-solvent solubility, and desiccated storage at −20 °C, while current OSCC evidence supports a separate carrier-free triterpene prodrug platform rather than direct evidence for BOP use.
-
Triterpene Prodrug for Targeted OSCC Therapy
2026-09-08
This study develops a carrier-free, self-assembled prodrug from glycyrrhetinic acid and ginsenoside Rh2 for targeted oral squamous cell carcinoma chemotherapy. Its central innovation is a thioketal-linked glycyrrhetinic acid dimer that uses tumor-associated reactive oxygen species to trigger drug release while glycyrrhetinic acid amplifies oxidative stress.